Synthesis and Evaluation of a Mitochondria-Targeting Poly(ADP-ribose) Polymerase-1 Inhibitor-Reference-Cited by-同舟云学术

Synthesis and Evaluation of a Mitochondria-Targeting Poly(ADP-ribose) Polymerase-1 Inhibitor

Published:2018-09-05 Issue:10 Volume:13 Page:2868-2879
ISSN:1554-8929
Container-title:ACS Chemical Biology
language:en
Short-container-title:ACS Chem. Biol.

Author:

Krainz Tanja¹,Lamade Andrew M.²,Du Lina²,Maskrey Taber S.¹,Calderon Michael J.³,Watkins Simon C.³,Epperly Michael W.⁴,Greenberger Joel S.⁴,Bayır Hülya²⁵⁶,Wipf Peter¹,Clark Robert S. B.²⁶^ORCID

Affiliation:

1. Department of Chemistry, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, United States

2. Department of Critical Care Medicine, Safar Center for Resuscitation Research, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15260, United States

3. Department of Cell Biology, Center for Biologic Imaging, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, United States

4. Department of Radiation Oncology, Cancer Institute, University of Pittsburgh, Pittsburgh, Pennsylvania 15232, United States

5. Department of Environmental and Occupational Health, Center for Free Radical and Antioxidant Health, University of Pittsburgh, Pittsburgh, Pennsylvania 15224, United States

6. Children’s Neuroscience Institute, Department of Pediatrics, UPMC Children’s Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15224, United States

Funder

National Institutes of Health

UNKNOWN

Publisher

American Chemical Society (ACS)

Subject

Molecular Medicine,General Medicine,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acschembio.8b00423

Reference62 articles.

1. Therapeutic applications of PARP inhibitors: Anticancer therapy and beyond

2. Biology of Poly(ADP-Ribose) Polymerases: The Factotums of Cell Maintenance